通过重塑脂肪细胞的脂质代谢与多酸载荷酶活性框架,可逆转骨质疏松性骨髓
Wenzheng Lin1,2,3, Suyu Gu1,3, Xing Zhang1
1Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, P. R. China.
Nature communications
|August 27, 2025
概括
骨髓脂肪细胞 (BMAds) 在骨质疏松症中通过分泌脂质恶化骨健康. 一个新的仿生框架 (CZP@LC) 针对这些BMAds,通过阻止有害的脂质交叉声和细胞衰老来恢复骨健康.
科学领域:
- 生物医学工程
- 细胞生物学
- 代谢疾病
背景情况:
- 骨质疏松症的特征是骨质损失和骨髓微环境的改变.
- 在骨质疏松症中观察到骨髓脂肪细胞 (BMAds) 的积累,但它们的确切功能尚不清楚.
- 通过脂质分泌和与其他骨髓细胞的交叉声响,BMAds可能会对骨健康产生负面影响.
研究的目的:
- 阐明BMAds在骨质疏松性骨髓微环境中的作用.
- 研究BMAds与邻近细胞之间的脂质交叉声机制.
- 制定一个有针对性的治疗策略,以抵消BMAd引起的骨恶化.
主要方法:
- 来自骨质疏松症模型的骨髓脂质学数据分析.
- 设计和应用一个多负载生物模拟双站点框架 (CZP@LC).
- 在骨髓细胞中评估线粒体功能,细胞衰老和骨质生成.
主要成果:
- BMAds分泌的脂质会损害线粒体的功能,并诱导邻近细胞的衰老.
- 在CZP@LC框架有效地针对BMAds,破坏脂质交叉声.
- 通过CZP@LC中断脂质代谢和沟通,缓解细胞衰老并恢复骨质生成.
结论:
- 骨质疏松症中BMAd的积累通过脂质分泌导致骨微环境的恶化.
- 在BMAds中准脂质代谢和交叉听力为骨质疏松症提供了一个有前途的治疗策略.
- 开发的仿生框架显示了针对骨质疏松症相关骨损失的生物治疗的潜力.
相关概念视频
Osteoclasts in Bone Remodeling
3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K
Bone Remodeling
38.5K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.5K


